4E2-17047-82661
3 vaccinations
7 coded responses
32 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 296 / SC
- Registered
- 2021-06-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-06-03
Dose 1 — Moderna
-
2021-06-13
Registered in v-safe
- 2021-06-13
- 2021-06-17
- 2021-06-24
-
2021-06-29
Dose 2 — Moderna
-
2021-06-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-07-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Muscle or body aches, DiarrheaAdult check-in
- 2021-07-03
-
2021-07-04
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain — Feeling: GoodFree text: Tenderness at injection site very mildMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-05
- 2021-07-06
- 2021-07-13
- 2021-07-20
- 2021-07-27
- 2021-08-03
- 2021-08-10
-
2021-09-28
Survey response — 3 months, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2021-12-28
-
2021-12-31
Dose 3 — Moderna
- 2021-12-31
-
2022-01-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, NauseaAdult check-in
- 2022-01-02
-
2022-01-03
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
-
2022-01-04
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Redness, Swelling · NoneAdult check-in
-
2022-01-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-06
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2022-01-09
Health check-in — day 7, dose 3Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-14
-
2022-01-21
Survey response — day 21, dose 3MedDRA: Cough, Diarrhoea, Oropharyngeal pain — Feeling: FairFree text: Sore throat, cough, diarrhea,MedDRA releases: 2024-11 · check-in free text available
- 2022-01-28
-
2022-02-04
Survey response — day 35, dose 3MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea — Feeling: FairFree text: Cold, runny nose, congestionMedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Survey response — day 42, dose 3MedDRA: Cough, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Cough, congestion.MedDRA releases: 2024-11 · check-in free text available
-
2022-02-13
Report sent to call center — day 42, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-02-17
-
2022-04-01
Survey response — 3 months, dose 3MedDRA: No adverse event — Feeling: GoodFree text: No health issues at this time.MedDRA releases: 2024-11 · check-in free text available
- 2022-07-01
-
2022-12-31
Survey response — 12 months, dose 3MedDRA: Cough, Oropharyngeal pain, Paranasal sinus discomfort — Feeling: FairFree text: Sore throat, cough, sinus pressureMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-06-03 | Moderna | |
| 2 | 2021-06-29 | Moderna | No |
| 3 | 2021-12-31 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-13 | Unsuccessful |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Tenderness at injection site very mild
Release 9 — 3 months, dose 2
Symptoms: Fatigue
Release 11 — day 21, dose 3
Symptoms: Sore throat, cough, diarrhea,
Release 11 — day 35, dose 3
Symptoms: Cold, runny nose, congestion
Release 11 — day 42, dose 3
Symptoms: Cough, congestion.
Release 11 — 3 months, dose 3
Symptoms: No health issues at this time.
Release 12 — 12 months, dose 3
Symptoms: Sore throat, cough, sinus pressure
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | No adverse event | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release